Lauren Thornton
Women's Health · Indianapolis, INNPI 1720662158
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $471 of the $570 with a category attached, or 82.6%. 13 manufacturers reported payments, led by Astellas Pharma US Inc at 28.6% of the total. 2025 is the largest year on record at $291, 6.6 times the $44 reported in 2022.
Across 25 payments — averaging $22.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$163
- Exact Sciences$66
- AbbVie$62
- Biogen$48
- Hologic Sales And Service, LLC$47
- Coopersurgical, Inc.$31
- plus $152 from 7 others
What the payments were for
- Food & beverage$47183%
- Education$9917%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 5 | $163 |
| Exact Sciences | 3 | $66 |
| AbbVie | 4 | $62 |
| Biogen | 2 | $48 |
| Hologic Sales And Service, LLC | 1 | $47 |
| Coopersurgical, Inc. | 2 | $31 |
| Bayer | 2 | $31 |
| Shield Therapeutics Inc | 1 | $24 |
| Coloplast | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Merck | 1 | $17 |
| Pfizer | 1 | $17 |
How this compares
$570 in reported general payments places this provider in the 65th percentile of 142 women's health providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 32 | $1,961 |
| Acyclovir | 13 | $104 |
Paid to pharmacies, not to this prescriber.
Other women's health in Indianapolis
- Cara RaunickIndianapolis$73K
- Courtney CortezIndianapolis$5K
- Kesha KellyIndianapolis$4K
- Lara NaanouhIndianapolis$2K
- Susan LogsdonIndianapolis$2K
- Lisa Chan OwensbyIndianapolis$1K
- Ninya WilkersonIndianapolis$687
- Jennifer BrownIndianapolis$672
- Kara MortonIndianapolis$622
- Jordan RamirezIndianapolis$561
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.